Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -153.04% is 110% below its 5-year average of -72.86%, near the low end of its 5-year range (-174.29%–-29.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.25% below its 12-month average of -118.41%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -153.04%.
RETURN ON INVESTED CAPITAL (ROIC)
-153.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-118.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-86.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-72.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-91.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-113.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.25%
CURRENT VS 3Y AVG
-77.23%
CURRENT VS 5Y AVG
-110.05%
CURRENT VS 10Y AVG
-68.07%
CURRENT VS 15Y AVG
-35.29%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-329.36%
vs the sector median at left
InspireMD, Inc.
Market Cap
$24.60M
Return on Invested Capital (ROIC)
-153.04%
TTM Avg
-118.41%
3Y Avg
-86.35%
5Y Avg
-72.86%
Market Cap
$24.44M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$24.13M
Return on Invested Capital (ROIC)
-78.16%
TTM Avg
-118.00%
3Y Avg
-120.55%
5Y Avg
-93.95%
Market Cap
$25.22M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$23.38M
Return on Invested Capital (ROIC)
-11.84%
TTM Avg
-13.28%
3Y Avg
-6.37%
5Y Avg
-38.08%
Market Cap
$23.06M
Return on Invested Capital (ROIC)
-36.89%
TTM Avg
-112.27%
3Y Avg
-56.18%
5Y Avg
-37.49%
Market Cap
$22.68M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-225.06%
3Y Avg
-147.38%
5Y Avg
-102.77%
Market Cap
$22.25M
Return on Invested Capital (ROIC)
-253.57%
TTM Avg
-160.85%
3Y Avg
-171.27%
5Y Avg
-226.34%
Market Cap
$27.03M
Return on Invested Capital (ROIC)
-3850.16%
TTM Avg
-607.40%
3Y Avg
-426.96%
5Y Avg
-426.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $24.60M | -153.04% | -118.41% | -86.35% | -72.86% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -146.30% | -66.51% | -47.74% | -43.26% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | -78.16% | -118.00% | -120.55% | -93.95% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -53.34% | -80.89% | -129.43% | -113.96% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | -11.84% | -13.28% | -6.37% | -38.08% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | -36.89% | -112.27% | -56.18% | -37.49% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | -248.21% | -225.06% | -147.38% | -102.77% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | -253.57% | -160.85% | -171.27% | -226.34% |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | -3850.16% | -607.40% | -426.96% | -426.96% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -14.21% | -12.54% | -12.42% | -37.50% |
ROIC
-153.0%
ROE
-122.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -153.04% |
| 2026-03-31 | -110.85% |
| 2025-12-31 | -84.53% |
| 2025-09-30 | -69.32% |
| 2025-06-30 | -174.29% |
| 2025-03-31 | -119.95% |
| 2024-12-31 | -85.62% |
| 2024-09-30 | -69.29% |
| 2024-06-30 | -55.70% |
| 2024-03-31 | -65.07% |
| 2023-12-31 | -50.80% |
| 2023-09-30 | -44.72% |
| 2023-06-30 | -39.42% |
| 2023-03-31 | -119.76% |
| 2022-12-31 | -95.56% |
| 2022-09-30 | -73.48% |
| 2022-06-30 | -61.06% |
| 2022-03-31 | -50.47% |
| 2021-12-31 | -41.61% |
| 2021-09-30 | -37.30% |
| 2021-06-30 | -29.67% |
| 2021-03-31 | -25.50% |
| 2020-12-31 | -73.76% |
| 2020-09-30 | -70.31% |
| 2020-06-30 | -61.90% |
| 2020-03-31 | -182.08% |
| 2019-12-31 | -145.10% |
| 2019-09-30 | -102.33% |
| 2019-06-30 | -129.42% |
| 2019-03-31 | -118.44% |
| 2018-12-31 | -81.24% |
| 2018-09-30 | -59.29% |
| 2018-06-30 | -99.56% |
| 2018-03-31 | -179.70% |
| 2017-12-31 | -227.09% |
| 2017-09-30 | -193.03% |
| 2017-06-30 | -129.03% |
| 2017-03-31 | -92.31% |
| 2016-12-31 | -99.08% |
| 2016-09-30 | -77.86% |
| 2016-03-31 | -783.88% |
| 2015-12-31 | -468.32% |
| 2015-09-30 | -256.86% |
| 2015-06-30 | -189.22% |
| 2015-03-31 | -163.14% |
| 2014-12-31 | -348.76% |
| 2014-09-30 | -475.33% |
| 2014-06-30 | -211.60% |
| 2014-03-31 | -96.73% |
| 2013-09-30 | -114.89% |
| 2013-06-30 | -90.25% |
| 2013-03-31 | -229.67% |
| 2012-12-31 | -168.95% |
| 2012-09-30 | -178.27% |
| 2012-06-30 | -137.67% |
| 2012-03-31 | -306.41% |
| 2011-12-31 | -192.88% |
| 2011-09-30 | -63.48% |
| 2011-06-30 | -43.42% |
| 2011-03-31 | -12.43% |
| 2010-03-31 | -1.11% |
